Related Experiment Video

Updated: May 24, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

[Selection and anti-cancer effects of siRNAs targeting HMGA2 gene]

Qi-Zhao Wang1, Yu-Hua Gong, Ying-Hui Lü

  • 1Institute of Molecular Medicine, Huaqiao University, Quanzhou 362021, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|March 2, 2012
PubMed

Insights

Small interfering RNAs (siRNAs) targeting the High Mobility Group A2 gene (HMGA2) effectively inhibit lung cancer cell growth, migration, and proliferation. HMGA2 siRNA5 demonstrated the most significant therapeutic potential for lung cancer gene therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Context:

  • High mobility group A2 protein (HMGA2) is overexpressed in lung cancers, presenting a potential therapeutic target.
  • RNA interference (RNAi) offers a cost-effective and efficient gene silencing approach for therapeutic applications.

Purpose:

  • To design and evaluate the efficacy of five small interfering RNAs (siRNAs) targeting the HMGA2 gene in human lung cancer cell lines.
  • To assess the impact of HMGA2-targeting siRNAs on lung cancer cell proliferation, colony formation, migration, and apoptosis.

Summary:

  • Five siRNAs targeting the HMGA2 gene were synthesized and tested on NCI-H446 and A549 lung cancer cell lines.
  • HMGA2 siRNA1, 3, and 5 demonstrated significant effects on cell proliferation, clone formation, migration, and apoptosis.
  • HMGA2 siRNA5 exhibited the strongest inhibitory effects, proving to be sequence-specific and not inducing an interferon response.

Impact:

  • HMGA2-targeting siRNAs show promise as a potential gene therapy strategy for lung cancer.
  • This study validates the therapeutic potential of targeting HMGA2 in lung cancer treatment.

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...